Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

NCT01562444 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Tick Borne Encephalitis
Virus Diseases

Interventions

OTHER: Blood draw

Sponsor

GlaxoSmithKline

Collaborators

[object Object]